Professor Loi challenged the dogma that immunotherapy was not possible with breast cancer and led a series of treatment trials that are already changing the lives of her patients. She was also the first to show that immune cell infiltration of breast tumour tissue strongly predicts improved survival in some types of breast cancer, and led the development and standardisation of this unique biomarker – to where it is now routine in the pathology work-up of breast cancers. Read more: https://aahms.org/news/scientists-honoured-with-jian-zhou-medals/
